Latest Atlas Venture Life Science Advisors, LLC Stock Portfolio
Atlas Venture Life Science Advisors, LLC Performance:
2024 Q3: 10.68%YTD: 39.52%2023: -20.23%
Performance for 2024 Q3 is 10.68%, and YTD is 39.52%, and 2023 is -20.23%.
About Atlas Venture Life Science Advisors, LLC and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Atlas Venture Life Science Advisors, LLC reported an equity portfolio of $1.1 Billions as of 30 Sep, 2024.
The top stock holdings of Atlas Venture Life Science Advisors, LLC are DYN, KYMR, THRD. The fund has invested 26.7% of it's portfolio in DYNE THERAPEUTICS, INC. and 21.5% of portfolio in KYMERA THERAPEUTICS, INC.
The fund managers got completely rid off REPLIMUNE GROUP, INC. (REPL) stocks. They significantly reduced their stock positions in DIANTHUS THERAPEUTICS, INC., SPERO THERAPEUTICS, INC. (SPRO) and KYMERA THERAPEUTICS, INC. (KYMR).
The top stock holdings of Atlas Venture Life Science Advisors, LLC are DYN, KYMR, THRD. The fund has invested 26.7% of it's portfolio in DYNE THERAPEUTICS, INC. and 21.5% of portfolio in KYMERA THERAPEUTICS, INC.
The fund managers got completely rid off REPLIMUNE GROUP, INC. (REPL) stocks. They significantly reduced their stock positions in DIANTHUS THERAPEUTICS, INC., SPERO THERAPEUTICS, INC. (SPRO) and KYMERA THERAPEUTICS, INC. (KYMR).
Atlas Venture Life Science Advisors, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Atlas Venture Life Science Advisors, LLC made a return of 10.68% in the last quarter. In trailing 12 months, it's portfolio return was 55.23%.
New Buys
Additions
Reductions
| Ticker | % Reduced |
|---|---|
| dianthus therapeutics, inc. | -43.8 |
| spero therapeutics, inc. | -24.74 |
| kymera therapeutics, inc. | -8.48 |
Atlas Venture Life Science Advisors, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| replimune group, inc. | -18,884,700 |
Atlas Venture Life Science Advisors, LLC got rid off the above stocks
Sector Distribution
Atlas Venture Life Science Advisors, LLC has about 75.1% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 75.1 |
| Others | 24.9 |
Market Cap. Distribution
Atlas Venture Life Science Advisors, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 48.2 |
| UNALLOCATED | 24.9 |
| SMALL-CAP | 22 |
| MICRO-CAP | 4.6 |
Stocks belong to which Index?
About 75.1% of the stocks held by Atlas Venture Life Science Advisors, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 75.1 |
| Others | 24.9 |
Atlas Venture Life Science Advisors, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Atlas Venture Life Science Advisors, LLC
Atlas Venture Life Science Advisors, LLC has 14 stocks in it's portfolio. About 98.6% of the portfolio is in top 10 stocks. VIGL proved to be the most loss making stock for the portfolio. KYMR was the most profitable stock for Atlas Venture Life Science Advisors, LLC last quarter.
Last Reported on: 13 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| AVTE | aerovate therapeutics, inc. | 0.35 | 1,799,230 | 3,760,400 | unchanged | 0.00 | ||
| DAWN | day one biopharmaceuticals, inc. | 8.30 | 6,430,260 | 89,573,500 | unchanged | 0.00 | ||
| DYN | dyne therapeutics, inc. | 26.71 | 8,020,140 | 288,083,000 | unchanged | 0.00 | ||
| GBIO | generation bio, co. | 1.90 | 8,279,480 | 20,450,300 | unchanged | 0.00 | ||
| IKNA | ikena oncology, inc. | 0.80 | 5,018,180 | 8,681,450 | unchanged | 0.00 | ||
| KYMR | kymera therapeutics, inc. | 21.48 | 4,896,460 | 231,750,000 | reduced | -8.48 | ||
| REPL | replimune group, inc. | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| SPRO | spero therapeutics, inc. | 0.05 | 402,885 | 539,866 | reduced | -24.74 | ||
| THRD | third harmonic bio, inc. | 13.70 | 10,907,900 | 147,801,000 | unchanged | 0.00 | ||
| VIGL | vigil neuroscience, inc. | 1.84 | 5,836,870 | 19,845,400 | unchanged | 0.00 | ||
| disc medicine, inc. | 11.43 | 2,509,460 | 123,315,000 | unchanged | 0.00 | |||
| q32 bio, inc. | 8.65 | 2,092,110 | 93,349,800 | unchanged | 0.00 | |||
| korro bio, inc. | 3.52 | 1,137,150 | 38,003,500 | unchanged | 0.00 | |||
| tectonic therapeutics, inc. | 1.06 | 378,447 | 11,466,900 | unchanged | 0.00 | |||
| dianthus therapeutics, inc. | 0.20 | 76,979 | 2,107,680 | reduced | -43.8 | |||